Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma.
Yang
Shih-Hung
SH
Kuo
Sung-Hsin
SH
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006509:Hepatitis B / Q000150:complications; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008111:Liver Function Tests; D008224:Lymphoma, Follicular / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D009367:Neoplasm Staging; D000069283:Rituximab; D016896:Treatment Outcome; D014775:Virus Activation
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D000069283:Rituximab